We are live on ! Find out more
Fayez Sarofim & Co

Fayez Sarofim & Co Portfolio holdings

AUM $42.5B
1-Year Est. Return 18.19%
This Fund
S&P 500
This Quarter Est. Return
+0.3%
1 Year Est. Return
+18.19%
3 Year Est. Return
+63.85%
5 Year Est. Return
+89.78%
10 Year Est. Return
+309.54%
AUM
$41.1B
AUM Growth
+$1.81B
Cap. Flow
+$2.06B
Cap. Flow %
5%
Top 10 Hldgs %
42.56%
Holding
315
New
30
Increased
123
Reduced
65
Closed
3

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$267M
2
DE icon
Deere & Co
DE
+$139M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$117M
4
JPM icon
JPMorgan Chase
JPM
+$114M
5
CVX icon
Chevron
CVX
+$88.5M

Top Sells

Rank Stock Value
1
NVO
Novo Nordisk
NVO
+$90M
2
CMCSA icon
Comcast
CMCSA
+$36M
3
UNP icon
Union Pacific
UNP
+$19.2M
4
HES
Hess
HES
+$19.2M
5
KMPR icon
Kemper
KMPR
+$17.6M

Sector Composition

Rank Sector Weight
1 Technology 30.18%
2 Financials 18.99%
3 Healthcare 11.19%
4 Consumer Staples 11.19%
5 Energy 8.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WBA
176
DELISTED
Walgreens Boots Alliance
WBA
$1.18M ﹤0.01%
126,534
-26,145
-17% -$243K
BN icon
177
Brookfield
BN
$82.9B
$1.16M ﹤0.01%
+30,393
New +$1.14M
IYY icon
178
iShares Dow Jones US ETF
IYY
$3B
$1.14M ﹤0.01%
8,000
– –
RL icon
179
Ralph Lauren
RL
$20B
$1.13M ﹤0.01%
4,881
– –
VLO icon
180
Valero Energy
VLO
$114B
$1.09M ﹤0.01%
8,887
+1,765
+25% +$236K
DFS
181
DELISTED
Discover Financial Services
DFS
$1.05M ﹤0.01%
+6,077
New +$997K
IDXX icon
182
Idexx Laboratories
IDXX
$40.2B
$1.05M ﹤0.01%
2,529
-100
-4% -$43.9K
KMB icon
183
Kimberly-Clark
KMB
$32.8B
$1.02M ﹤0.01%
7,795
+1,288
+20% +$176K
QCOM icon
184
Qualcomm
QCOM
$201B
$1.02M ﹤0.01%
6,632
+33
+0.5% +$5.4K
EW icon
185
Edwards Lifesciences
EW
$49.4B
$1.02M ﹤0.01%
13,755
-210
-2% -$14.7K
IHG icon
186
InterContinental Hotels
IHG
$22.5B
$1.01M ﹤0.01%
8,075
+1,010
+14% +$121K
MPLX icon
187
MPLX
MPLX
$59.2B
$996K ﹤0.01%
20,814
– –
MLM icon
188
Martin Marietta Materials
MLM
$36B
$976K ﹤0.01%
1,890
+213
+13% +$121K
LRCX icon
189
Lam Research
LRCX
$339B
$939K ﹤0.01%
+13,000
New +$986K
GIS icon
190
General Mills
GIS
$19.6B
$919K ﹤0.01%
14,415
– –
CRM icon
191
Salesforce
CRM
$210B
$918K ﹤0.01%
2,746
+100
+4% +$31.9K
IJK icon
192
iShares S&P Mid-Cap 400 Growth ETF
IJK
$10.3B
$905K ﹤0.01%
9,949
+5,269
+113% +$496K
YUM icon
193
Yum! Brands
YUM
$38.4B
$896K ﹤0.01%
6,681
– –
HWC icon
194
Hancock Whitney
HWC
$6.09B
$895K ﹤0.01%
16,347
– –
AZO icon
195
AutoZone
AZO
$46.7B
$887K ﹤0.01%
277
+77
+39% +$244K
WMB icon
196
Williams Companies
WMB
$87.6B
$871K ﹤0.01%
16,085
– –
KMX icon
197
CarMax
KMX
$8.49B
$862K ﹤0.01%
+10,537
New +$828K
SYK icon
198
Stryker
SYK
$108B
$857K ﹤0.01%
2,380
+220
+10% +$81.5K
ENB icon
199
Enbridge
ENB
$106B
$840K ﹤0.01%
+19,807
New +$829K
NRG icon
200
NRG Energy
NRG
$22.3B
$825K ﹤0.01%
9,147
– –
6 7
8
9 10

Similar funds

PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
GAM
Gotham Asset Management New York $43B AUM 34.97% 1-Year Est. Return
Empower Advisory Group
Empower Advisory Group Greenwood Village, Colorado $41.9B AUM 18.91% 1-Year Est. Return
Newport Trust Company
Newport Trust Company Washington, District of Columbia $41.5B AUM 16.76% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $43.9B AUM 121.74% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return

Fayez Sarofim & Co's Q4 2024 Portfolio in Review

As of Q4 2024, Fayez Sarofim & Co held 315 positions worth $41.1B, up 4.6% from $39.3B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Fayez Sarofim & Co deployed $2.06B of net new capital in Q4 2024, opening 30 new positions and adding to 123 existing holdings. Its largest new stake was Copart: 158,575 shares worth $9.1M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Novo Nordisk, an estimated $90M trimmed.

  • Fayez Sarofim & Co's largest Q4 2024 buy was Copart: 158,575 shares worth $9.1M.
  • Fayez Sarofim & Co added most to NVIDIA in Q4 2024, an estimated $267M increase.
  • Fayez Sarofim & Co's biggest Q4 2024 reduction was Novo Nordisk, cutting an estimated $90M.
  • Fayez Sarofim & Co fully exited Bruker in Q4 2024, selling an estimated $227K.
  • Fayez Sarofim & Co's ten largest holdings make up 43% of its $41.1B portfolio in Q4 2024.
  • Fayez Sarofim & Co opened 30 new positions and closed 3 in Q4 2024.
  • Fayez Sarofim & Co's portfolio value rose 4.6% quarter-over-quarter to $41.1B.

Based on Fayez Sarofim & Co's 13F filing for Q4 2024, filed 14 Feb 2025.